Drug Safety in the Limelight

Wechsler,Jill;

CONTINUE TO SITE

OR WAIT null SECS

Spotlight

Analytics Dosage Forms Drug Development Manufacturing Outsourcing Quality Systems

AnalyticsDosage FormsDrug DevelopmentManufacturingOutsourcingQuality Systems

Topic

View More COVID-19 Update Analytical Method Development APIs Aseptic Processing Biologic Drugs Drug Delivery Equipment Excipients Formulation Packaging Process Control/PAT Process Development QA/QC Regulatory Action Supply Chain

COVID-19 UpdateAnalytical Method DevelopmentAPIsAseptic ProcessingBiologic DrugsDrug DeliveryEquipmentExcipientsFormulationPackagingProcess Control/PATProcess DevelopmentQA/QCRegulatory ActionSupply Chain

News

All News Bio/Pharma News

Publications

All Publications PharmTech PharmTech Europe

All PublicationsPharmTechPharmTech Europe

Resources

Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research Pharma Insights PharmTech Products Sponsored eBooks Sponsored Podcasts Sponsored Videos Whitepapers

MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharma InsightsPharmTech ProductsSponsored eBooksSponsored PodcastsSponsored VideosWhitepapers

Webcasts

Multimedia

All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk

All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk

Conference

Conference Coverage Conference Listing Events

Conference CoverageConference ListingEvents

About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Spotlight

Analytics
Dosage Forms
Drug Development
Manufacturing
Outsourcing
Quality Systems

TopicSee All >

COVID-19 Update
Analytical Method Development
APIs
Aseptic Processing
Biologic Drugs
Drug Delivery
Equipment
Excipients
Formulation
Packaging
Process Control/PAT
Process Development
QA/QC
Regulatory Action
Supply Chain

About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Drug Safety in the Limelight

Published on: May 2, 2003

Jill Wechsler

Pharmaceutical Technology, Pharmaceutical Technology-05-02-2003, Volume 27, Issue 5

FDA resolves the bar code labeling debate, releases its GMP requirements for dietary supplements, and proposes a comprehensive adverse-event reporting system.

Geopolitical Shifts Change Nature of Pharma Partnerships

FDA Grants Fast Track Designation to Q32 Bio Treatment for Alopecia Areata

CHMP Recommends argenx Treatment for Chronic Inflammatory Demyelinating Polyneuropathy